Quantum Corporation logo

Quantum Corporation (QMCO)

Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
9. 02
-0.73
-7.54%
$
46.74M Market Cap
- P/E Ratio
0% Div Yield
545,091 Volume
-0.07 Eps
$ 9.75
Previous Close
Day Range
8.91 9.8
Year Range
6.51 90.64
Want to track QMCO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days
First Quantum Minerals: Strong Q3 Shows Potential Beyond Cobre Panama

First Quantum Minerals: Strong Q3 Shows Potential Beyond Cobre Panama

First Quantum reported a strong Q3, with copper production rising 13% quarter-over-quarter despite Cobre Panama's suspension. Higher grades at Kansanshi and Sentinel reduced C1 cash costs by $0.16, strengthening margins, while gold production surged 20% QoQ, boosting revenue alongside resilient copper prices and record gold prices. Cobre Panama remains a key asset, with ongoing arbitration claims that could unlock significant upside. The market appears to be undervaluing the potential outcomes regarding the Cobre Panama mine closure.

Seekingalpha | 1 year ago
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd.

Accesswire | 1 year ago
The Quantum Computing Revolution is Here: 3 Top Stocks to Watch

The Quantum Computing Revolution is Here: 3 Top Stocks to Watch

Quantum computing is a revolutionary, next-generation technology used to solve complex equations. Stock Strategist Andrew Rocco explains that though its in its early stages, quantum computing is likely to disrupt several industries.

Zacks | 1 year ago
2 Quantum Computing Stocks To Watch In The Stock Market Today

2 Quantum Computing Stocks To Watch In The Stock Market Today

Quantum computing stocks to check out in the stock market right now.

Stockmarket | 1 year ago
Better Quantum Computing Stock: Microsoft vs. IonQ

Better Quantum Computing Stock: Microsoft vs. IonQ

These firms are building technology that could upend the computer industry.

Fool | 1 year ago
Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America

Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America

TORONTO, ON / ACCESSWIRE / October 7, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu" or the "Company"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness.

Accesswire | 1 year ago
Quantum, Veeam Team Up to Boost Data Protection and Cyber Resilience

Quantum, Veeam Team Up to Boost Data Protection and Cyber Resilience

QMCO strengthens its Veeam Ready qualifications to combat cyber threats and data recovery challenges effectively.

Zacks | 1 year ago
Quantum Biopharma Provides Corporate Update

Quantum Biopharma Provides Corporate Update

TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce the following corporate updates.

Accesswire | 1 year ago
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US

TORONTO, ON / ACCESSWIRE / September 25, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that Jason Sawyer, Head of Finance and Mergers and Acquisitions, will present at the ArcStone-Kingswood Growth Summit held on September 26, 2024, in Toronto, ON.

Accesswire | 1 year ago
Spectral Capital Corp (FCCN) Welcomes Quantum Visionary Dr. Wolf Kohn to Its Quantum Bridge Advisory Board

Spectral Capital Corp (FCCN) Welcomes Quantum Visionary Dr. Wolf Kohn to Its Quantum Bridge Advisory Board

Revolutionizing the Future of Quantum Computing and AI with Industry Luminary Dr. Wolf Kohn NEW YORK, NY / ACCESSWIRE / September 24, 2024 / Spectral Capital Corporation (OTCQB:FCCN), a trailblazer in Quantum-as-a-Service (QaaS) and decentralized cloud infrastructure, is thrilled to announce the appointment of Dr. Wolf Kohn, Ph.D., a globally recognized leader in quantum computing, artificial intelligence, and data optimization, to its Quantum Bridge Advisory Board.

Accesswire | 1 year ago
Exclusive: First Quantum Minerals offers voluntary retirement to Cobre Panama workers, sources say

Exclusive: First Quantum Minerals offers voluntary retirement to Cobre Panama workers, sources say

Canadian miner First Quantum Minerals has opened a voluntary retirement (VR) scheme to workers at the Cobre Panama mine, two sources familiar with the matter told Reuters, as the company waits for a government decision on re-opening the facility.

Reuters | 1 year ago
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis

TORONTO, ON / ACCESSWIRE / September 9, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that through its subsidiary, HUGE Biopharma Australia Pty Ltd.

Accesswire | 1 year ago
Loading...
Load More